Lyonbiopole is a partner of the ASSET project funded by the European Commission.
ASSET brings together 14 partners and aims to develop a method to better meet the scientific and societal challenges raised by pandemics and the related crisis management. The project will run for four years (January 2014 to December 2017).
Its primary objective is to establish knowledge and experiences in order to identify the scientific (e.g. implementing new vaccines and treatments) and societal (e.g. population reactions to vaccination and public authority communication policies) issues raised by epidemics and the related management crises. It also aims to explore and situate social science issues in widespread epidemics and define and test a participative strategy to overcome the various issues raised.
Consistent with its work on systems medicine, Lyonbiopole has partnered with the CASyM project funded by the European Commission under FP7. This project, which involves 22 partners, will run for four years. It aims to establish a strategic roadmap for the sustainable, effective introduction of systems medicine in Europe.
The CASyM project results will greatly influence future European Commission calls for projects under H2020. The cluster organised a BIOVISION satellite event in 2013, the first CASyM Stakeholders Conference; 150 experts from 20 countries came to participate in the lectures and 10 round tables.
A second networking event was organised on 10 April 2014 in Lyon.